DUALITYBIO-B (09606): Hua Haiqing appointed as an executive director of the company.
Ening Biology-B (09606) announced that from March 23, 2026: (1) Ms. Si Wen resigned as an executive director of the company and a member of the compensation committee; (2) Dr. Hua Haiqing was appointed as an executive director of the company; (3) Mr. Zhang Shaoren was appointed as the company's Chief Financial Officer; (4) Dr. Zhu Zhongyuan was appointed as a member of the company's compensation committee.
DUALITYBIO-B (09606) announcement: Starting from March 23, 2026, (1) Ms. Si Wen resigns as the company's executive director and member of the Compensation Committee; (2) Dr. Huaha Qing is appointed as the company's executive director; (3) Mr. Zhang Shaoren is appointed as the company's Chief Financial Officer; (4) Dr. Zhu Zhongyuan is appointed as a member of the company's Compensation Committee.
Related Articles
DONGGUANG CHEM (01702) will distribute a final dividend of HK$0.04 per share on June 12th.
MEDIWELCOME (02159) released its annual performance results, with a net profit attributable to shareholders of 9.988 million yuan, turning losses into profits year-on-year.
Green Tea Group (06831) released its annual performance for 2025, with a net profit attributable to shareholders of 486 million yuan, an increase of 38.9% year-on-year.
DONGGUANG CHEM (01702) will distribute a final dividend of HK$0.04 per share on June 12th.
MEDIWELCOME (02159) released its annual performance results, with a net profit attributable to shareholders of 9.988 million yuan, turning losses into profits year-on-year.
Green Tea Group (06831) released its annual performance for 2025, with a net profit attributable to shareholders of 486 million yuan, an increase of 38.9% year-on-year.
